Resource Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
$281K Sell
4,500
-400
-8% -$23.5K 0.03% 152
2021
Q3
$290K Buy
4,900
+1
+0% +$66 0.03% 146
2021
Q2
$327K Buy
4,899
+400
+9% +$26.1K 0.04% 143
2021
Q1
$284K Sell
4,499
-4,499
-50% -$280K 0.03% 141
2020
Q4
$558K Sell
8,998
-115
-1% -$7.07K 0.08% 93
2020
Q3
$549K Buy
9,113
+3,098
+52% +$186K 0.09% 80
2020
Q2
$353K Buy
6,015
+1,686
+39% +$101K 0.06% 96
2020
Q1
$241K Buy
4,329
+965
+29% +$59K 0.05% 115
2019
Q4
$216K Buy
+3,364
New +$193K 0.03% 140
2018
Q2
Sell
-4,081
Closed -$258K 132
2018
Q1
$258K Hold
4,081
0.06% 105
2017
Q4
$261K Buy
+4,081
New +$255K 0.05% 107

Other funds holding BMY

Resource Management's BMY Position: Q4 2021 in Review

Resource Management reduced its Bristol-Myers Squibb (BMY) stake by 8.2% in Q4 2021, selling an estimated $23.5K and leaving 4,500 shares worth $281K. The position accounts for 0.03% of the portfolio, ranked #152.

Resource Management first reported a position in BMY in Q4 2017 and has held it in 11 quarters since. The position peaked at $558K in Q4 2020. 2,445 funds tracked by Wall St. Rank hold BMY as of Q4 2021.

  • Resource Management held 4,500 shares of Bristol-Myers Squibb worth $281K as of Q4 2021.
  • Resource Management sold 400 Bristol-Myers Squibb shares in Q4 2021, an estimated $23.5K.
  • Bristol-Myers Squibb made up 0.03% of Resource Management's portfolio in Q4 2021, its #152 holding.
  • Resource Management first reported a position in Bristol-Myers Squibb in Q4 2017 and has held it in 11 quarters since.
  • Resource Management's Bristol-Myers Squibb position peaked at $558K in Q4 2020.
  • 2,445 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2021.

Based on Resource Management's 13F filing for Q4 2021, filed 14 Feb 2022.